Results 31 to 40 of about 11,635 (130)
The mechanism of HA‐DS@PLGA nanoparticles co‐delivering DOX and SNAP (an NO donor) to suppress tumor growth, remodel the tumor microenvironment, and enhance antitumor immune responses for effective combinatorial cancer therapy. Abstract Cancer therapeutic efficacy is significantly influenced by tumor immunosuppressive environment possibly induced by ...
Xingzhou Peng +10 more
wiley +1 more source
Synthesis and chelating properties of substituted formyl pyridine thiosemicarbazones of potential biological activity [PDF]
The synthesis of a series of 4-(un)substituted thiosemicarbazones of 6-methyl-5-nitropyridine-2-carboxaldehyde, I (R = H, n-Bu, 4-ClC6H4, etc.), is reported by two different routes. The prepd. compds.
Hoda Hassan
doaj +1 more source
Genetic Etiologies of Dystonia with Anarthria/Aphonia
Abstract Background Dystonia with anarthria and/or aphonia (DAnAp) represents a distinctive phenotype manifesting across lifespan. Frequently associated with genetic disorders, early recognition is critical for diagnosis and management. Objectives To provide practical recommendations for the clinical evaluation of patients with DAnAp, enhancing ...
Anika Ménétrey +7 more
wiley +1 more source
Prevalence and Associations of Abnormal Levels of Vitamin B6 in People with Parkinson's Disease
Abstract Background In people with Parkinson's disease, abnormal levels of vitamin B6 may be associated with polyneuropathy and epileptic seizures, including medication‐refractory status epilepticus. Objectives To estimate the prevalence and explore associations of abnormal levels of vitamin B6 in people with Parkinson's disease.
Karlo J. Lizarraga +7 more
wiley +1 more source
A hydrogen‐bond‐donating NO donor was designed to interact specifically with the hydrogel network, thereby minimizing donor leakage and achieving prolonged NO release. Abstract Nitric oxide (NO)‐releasing materials have attracted considerable interest for their potential in diverse biomedical applications.
Yixin Zhu +8 more
wiley +1 more source
Background and Objective: Wilson’s disease (WD) is caused by mutation to the cooer-transporting gene ATP7B. Chelation therapy is the main protochol of treatment for patients with Wilson’s disease.
Fani N +4 more
doaj
Response to different therapeutic approaches in Wilson disease. A long-term follow up study
Background and aims. There are certain areas of uncertainty regarding the best therapeutic approach in patients diagnosed with Wilson Disease (WD). Our aim was to assess treatment response to different therapies in a cohort of WD patients followed in a ...
Beatriz Rodríguez +2 more
doaj +1 more source
ABSTRACT Background Challenges in establishing clinical conventional in vitro fertilization (IVF) in horses include variation in sperm and oocyte quality, which can be affected by mare age. Extended preincubation of stallion spermatozoa has resulted in successful IVF.
Raul A. Gonzalez‐Castro +6 more
wiley +1 more source
Enteroendocrine L cells function as chemosensors in the intestine. Using the L‐cell line GLUTag, we show that distinct nutrients trigger different combinations of co‐secretion of GLP‐1 and neurotransmitters: D‐glucose evokes GLP‐1, glutamate, and ATP; L‐glutamine evokes GLP‐1 and glutamate; sucralose and butyrate evoke only GLP‐1.
Yo Ito +5 more
wiley +1 more source
Repression of Virulence in Staphylococcus aureus by 2‐Aminothiol‐Mediated Quorum Quenching
Simple analogues of cysteine that can eliminate the native autoinducing peptides (AIPs) of staphylococci extracellularly, before they activate their receptor, and turn off quorum sensing in different Staphylococcus aureus. The elimination of AIPs occurs through a mechanism similar to native chemical ligation (NCL). Further, this strategy showed promise
Bengt H. Gless +5 more
wiley +2 more sources

